Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

ConclusionsOur research ’s findings proposed CoQ10 supplementation as an adjuvant to saline hydration as a preventive approach against CI-AKI.Trial registrationThe trial was registered at Iranian Registry of Clinical Trials (https://www.irct.ir/trial/60435, identifier code: IRCT20120215009014N414). Registration date: 2021 –12-29.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research